The Claim
Statin therapy reduces the risk of major coronary events by 39–43% and coronary revascularizations by 37–48% per 1.0 mmol/L reduction in LDL cholesterol in individuals with a 5-year vascular risk below 10%, with no increase in cancer incidence or mortality.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with a low 5-year risk of vascular disease, taking statins lowers the chance of heart attacks and procedures to open blocked arteries by a specific amount for every 1.0 mmol/L drop in LDL cholesterol, and does not raise the risk of cancer or death from cancer.
See the scientific wording
Statin therapy reduces the risk of major coronary events by 39–43% and coronary revascularizations by 37–48% per 1.0 mmol/L LDL reduction in individuals with a 5-year vascular risk below 10%, with no evidence of increased cancer incidence or mortality.
Lowering LDL cholesterol in the blood stops more fatty deposits from building up inside artery walls, causes existing deposits to become harder and less likely to rupture, and reduces swelling in the artery walls. This prevents blockages that cause heart attacks and the need for artery-opening procedures.
What the research says
1 studyThis study found that for people at low risk of heart disease, taking statins to lower cholesterol reduced heart attacks and artery-opening procedures by nearly half, without increasing cancer risk — exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.